Bioventus to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
Bioventus (Nasdaq: BVS), a global leader in innovations for active healing, has announced its participation in the upcoming Morgan Stanley Global Healthcare Conference. Mark Singleton, the company's Senior Vice-President and Chief Financial Officer, will engage in a fireside chat on September 10, 2025, at 1:05 p.m. ET.
Investors can access a live webcast of the presentation through the "Investors" section of Bioventus's website at www.bioventus.com, with a replay option available after the event.
Bioventus (Nasdaq: BVS), leader mondiale nelle innovazioni per la guarigione attiva, ha annunciato la sua partecipazione alla prossima Morgan Stanley Global Healthcare Conference. Mark Singleton, Senior Vice President e Chief Financial Officer dell'azienda, parteciperà a una fireside chat il 10 settembre 2025 alle 13:05 ET.
Gli investitori potranno seguire la presentazione in diretta streaming nella sezione "Investors" del sito web di Bioventus all'indirizzo www.bioventus.com; sarà disponibile anche la replica dopo l'evento.
Bioventus (Nasdaq: BVS), líder mundial en innovaciones para la curación activa, ha anunciado su participación en la próxima Morgan Stanley Global Healthcare Conference. Mark Singleton, vicepresidente senior y director financiero de la compañía, participará en una charla informal el 10 de septiembre de 2025 a la 1:05 p.m. ET.
Los inversores podrán acceder a la transmisión en vivo de la presentación desde la sección "Investors" del sitio web de Bioventus en www.bioventus.com; estará disponible una reproducción después del evento.
Bioventus (Nasdaq: BVS), 능동적 치유(Active Healing) 혁신 분야의 글로벌 선도기업이 다가오는 Morgan Stanley Global Healthcare Conference에 참가한다고 발표했습니다. 회사의 수석 부사장이자 최고재무책임자인 Mark Singleton이 2025년 9월 10일 오후 1시 05분(동부시간)에 파이어사이드 채팅에 참석합니다.
투자자들은 Bioventus 웹사이트의 "Investors" 섹션(www.bioventus.com)에서 발표를 실시간 웹캐스트로 시청할 수 있으며, 행사 후 재시청도 제공됩니다.
Bioventus (Nasdaq: BVS), leader mondial des innovations pour la guérison active, a annoncé sa participation à la prochaine Morgan Stanley Global Healthcare Conference. Mark Singleton, vice-président principal et directeur financier de l'entreprise, prendra part à une discussion informelle le 10 septembre 2025 à 13h05 ET.
Les investisseurs pourront suivre la présentation en webcast en direct depuis la rubrique "Investors" du site web de Bioventus à l'adresse www.bioventus.com ; un replay sera disponible après l'événement.
Bioventus (Nasdaq: BVS), ein weltweit führendes Unternehmen für Innovationen im Bereich Active Healing, hat seine Teilnahme an der bevorstehenden Morgan Stanley Global Healthcare Conference angekündigt. Mark Singleton, Senior Vice President und Chief Financial Officer des Unternehmens, wird an einem Fireside-Chat am 10. September 2025 um 13:05 Uhr ET teilnehmen.
Investoren können die Präsentation per Live-Webcast über den Bereich "Investors" auf der Bioventus-Website unter www.bioventus.com verfolgen; eine Wiederholung steht nach der Veranstaltung zur Verfügung.
- None.
- None.
DURHAM, N.C., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Mark Singleton, Bioventus Senior Vice-President and Chief Financial Officer, will participate in a fireside chat at the Morgan Stanley Global Healthcare Conference on Wednesday, September 10, 2025, at 1:05 p.m. ET.
A live webcast of the presentation will be available on the “Investors” section of the Company’s website at www.bioventus.com and will be available for replay on that site following the event.
About Bioventus
Bioventus delivers clinically proven, cost-effective products that help people heal quickly and safely. Its mission is to make a difference by helping patients resume and enjoy active lives. The Innovations for Active Healing from Bioventus include offerings for Pain Treatments, Restorative Therapies and Surgical Solutions. Built on a commitment to high quality standards, evidence-based medicine and strong ethical behavior, Bioventus is a trusted partner for physicians worldwide. For more information, visit www.bioventus.com, and follow the Company on LinkedIn and X. Bioventus and the Bioventus logo are registered trademarks of Bioventus LLC.
Investor and Media Contact:
Dave Crawford
919-474-6787
dave.crawford@bioventus.com
FAQ
When is Bioventus (BVS) presenting at the Morgan Stanley Healthcare Conference 2025?
Who will represent Bioventus (BVS) at the Morgan Stanley Healthcare Conference?
How can investors watch the Bioventus (BVS) Morgan Stanley conference presentation?
What topics will Bioventus (BVS) discuss at the Morgan Stanley Healthcare Conference?
